Enhanced Group is pushing performance medicine.
What’s happening: The parent company of the Enhanced Games—a sports competition where athletes can use medically supervised performance-enhancing drugs—went public via SPAC at a $1.2B valuation.
Backed by Peter Thiel, Christian Angermayer, and Donald Trump Jr.’s 1789 Capital, the company will host its inaugural event later this month.
Shell game. Designed for spectacle and controversy, the event doubles as a marketing engine for Live Enhanced, the company’s telehealth platform offering testosterone therapy, peptides, and longevity protocols.
Borrowing from Red Bull’s playbook, Enhanced uses elite athletes and entertainment to drive demand for what it calls “performance medicine,” leveraging competition as advertising for its prescriptions’ outcomes.
Altered egos. As demand for peptides, longevity therapies, and aesthetics-driven wellness accelerates, the Enhanced Games is pushing the limits of consumer healthcare — turning human optimization into the product.
Looking ahead: Normalizing PEDs for all, Enhanced is fueling a shift with unknown health and cultural consequences, where enhancement becomes an expectation, not an edge case.
